Asymmetric dimethylarginine induces TNF-α production via ROS/NF-κB dependent pathway in human monocytic cells and the inhibitory effect of reinioside C

Vascular Pharmacology

Volumn 48, Issue 2-3, 2008, Pages 115-121

  Zhang, Guo Gang ^a   Bai, Yong Ping ^a   Chen, Mei Fang ^a   Shi, Rui Zhen ^a   Jiang, De Jian ^a   Fu, Qiong Mei ^a   Tan, Gui Shan ^a   Li, Yuan Jian ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Asymmetric dimethylarginine; Monocytes; Nuclear factor B; Reactive oxygen species; Reinioside C; Tumor necrosis factor

Indexed keywords

ARGININE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; N(G),N(G) DIMETHYLARGININE; PLANT EXTRACT; PYRROLIDINE DITHIOCARBAMATE; REACTIVE OXYGEN METABOLITE; REINIOSIDE C; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; MEDICINAL PLANT; MONOCYTE; POLYGALA FALLAX; PRIORITY JOURNAL;

EID: 40149096187     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2008.01.004     Document Type: Article

References (30)

1. Bai Y.P. Zhang G.G. Shi R.Z. Li Y.J. Inhibitory effect of reinioside C on LOX-1 expression induced by ox-LDL Zhong Nan Da Xue Xue Bao Yi Xue Ban 31 2006 659 662
2. Bai Y.P. Liu Y.H. Chen J. Song T. You Y. Tang Z.Y. Li Y.J. Zhang G.G. Rosiglitazone attenuates NF-kappaB-dependent ICAM-1 and TNF-alpha production caused by homocysteine via inhibiting ERK1/2/p38MAPK activation Biochem. Biophys. Res. Commun. 360 2007 20 26
3. Boger R.H. Bode-Boger S.M. Sydow K. Heistad D.D. Lentz S.R. Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia Arterioscler. Thromb. Vasc. Biol. 20 2000 1557 1564
4. Chen M.F. Xie X.M. Yang T.L. Wang Y.J. Zhang X.H. Luo B.L. Li Y.J. Role of asymmetric dimethylarginine in inflammatory reactions by angiotensin II J. Vasc. Res. 44 2007 391 402
5. Del Fresno C. Soler-Rangel L. Soares-Schanoski A. Gómez-Piña V. González-León M.C. Gómez-García L. Mendoza-Barberá E. Rodríguez-Rojas A. García F. Fuentes-Prior P. Arnalich F. López-Collazo E. Inflammatory responses associated with acute coronary syndrome up-regulate IRAK-M and induce endotoxin tolerance in circulating monocytes J. Endotoxin Res. 13 2007 39 52
6. El Messal M. Beaudeux J.L. Drissi A. Giral P. Chater R. Bruckert E. Adlouni A. Chapman M.J. Elevated serum levels of proinflammatory cytokines and biomarkers of matrix remodeling in never-treated patients with familial hypercholesterolemia Clin. Chim. Acta. 366 2006 185 189
7. Guha M. Bai W. Nadler J.L. Natarajan R. Molecular mechanisms of tumor necrosis factor alpha gene expression in monocytic cells via hyperglycemia-induced oxidant stress-dependent and -independent pathways J. Biol. Chem. 275 2000 17728 17739
8. Jacobi J. Kristal B. Chezar J. Exogenous superoxide mediates pro-oxidative, pro-inflammatory, and pro-coagulatory changes in primary endothelial cell cultures Free Radic. Biol. Med. 39 2005 1238 1248
9. Jiang D.J. Hu G.Y. Jiang J.L. Xiang H.L. Deng H.W. Li Y.J. Relationship between protective effect of xanthone on endothelial cells and endogenous nitric oxide synthase inhibitors Bioorg. Med. Chem. 11 2003 5171 5177
10. Jiang D.J. Dai Z. Li Y.J. Pharmacological effects of xanthones as cardiovascular protective agents Cardiovasc. Drug Rev. 22 2004 91 102
11. Jiang D.J. Jia S.J. Dai Z. Li Y.J. Asymmetric dimethylarginine induces apoptosis via p38 MAPK/caspase-3-dependent signaling pathway in endothelial cells J. Mol. Cell. Cardiol. 40 2006 529 539
12. Jiang J.L. Wang S. Li N.S. Zhang X.H. Deng H.W. Li Y.J. The inhibitory effect of simvastatin on the ADMA-induced inflammatory reaction is mediated by MAPK pathways in endothelial cells Biochem. Cell. Biol. 85 2007 66 77
13. Krempl T.K. Maas R. Sydow K. Meinertz T. Böger R.H. Kähler J. Elevation of asymmetric dimethylarginine in patients with unstable angina and recurrent cardiovascular events Eur. Heart J. 26 2005 1846 1851
14. Lu T.M. Ding Y.A. Lin S.J. Lee W.S. Tai H.C. Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention Eur. Heart J. 24 2003 1912 1919
15. Lu T.M. Ding Y.A. Leu H.B. Yin W.H. Sheu W.H. Chu K.M. Effect of rosuvastatin on plasma levels of asymmetric dimethylarginine in patients with hypercholesterolemia Am. J. Cardiol. 94 2004 157 161
16. Miyazaki H. Matsuoka H. Cooke J.P. Usui M. Ueda S. Okuda S. Imaizumi T. Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis Circulation. 99 1999 1141 1146
17. Ogiwara F. Takahashi M. Ikeda U. Inflammatory markers and cytokines in cardiovascular disease Rinsho Byori 52 2004 686 692
18. Pasqui A.L. Di Renzo M. Bova G. Maffei S. Pompella G. Auteri A. Puccetti L. Pro-inflammatory/anti-inflammatory cytokine imbalance in acute coronary syndromes Clin. Exp. Med. 6 2006 38 44
19. Rus H. Niculescu F. Vlaicu R. Tumor necrosis factor-alpha in human arterial wall with atherosclerosis Atherosclerosis 89 1991 247 254
20. Siroen M.P. van Leeuwen P.A. Nijveldt R.J. Teerlink T. Wouters P.J. Van den Berghe G. Modulation of asymmetric dimethylarginine in critically ill patients receiving intensive insulin treatment: a possible explanation of reduced morbidity and mortality? Crit. Care Med. 33 2005 504 510
21. Smirnova I.V. Kajstura M. Sawamura T. Goligorsky M.S. Asymmetric dimethylarginine upregulates LOX-1 in activated macrophages: role in foam cell formation Am. J. Physiol, Heart Circ. Physiol. 287 2004 782 790
22. Stühlinger M. Asymmetric dimethyl arginine (ADMA): a novel cardiovascular risk factor? Wien Med. Wochenschr. 157 2007 57 60
23. Tan B. Jiang D.J. Huang H. Jia S.J. Jiang J.L. Hu C.P. Li Y.J. Taurine protects against low-density lipoprotein-induced endothelial dysfunction by the DDAH/ADMA pathway Vasc. Pharmacol. 46 2007 338 345
24. Wang Y.N. Che S.M. Ma A.Q. Clinical significance of serum cytokines IL-1beta, sIL-2R, IL-6, TNF-alpha, and IFN-v in acute coronary syndrome Chin. Med. Sci. J. 19 2004 120 124
25. Wang S. Jiang J.L. Hu C.P. Zhang X.J. Yang D.L. Li Y.J. Relationship between protective effects of rosiglitazone on endothelium and endogenous nitric oxide synthase inhibitor in streptozotocin-induced diabetic rats and cultured endothelial cells Diabetes Metab. Res. Rev. 23 2007 157 164
26. Wilson S.H. Caplice N.M. Simari R.D. Holmes D.R. Jr. Carlson P.J. Lerman A. Activated nuclear factor-kappaB is present in the coronary vasculature in experimental hypercholesterolemia Atherosclerosis 148 2000 23 30
27. Xu Kang-ping Huang Wei Tan Gui-shan Study on the Anti-hyperlipidemia Effective Constituent of Polygala fallax Hemsl Zhong Yao Cai 29 2006 16 18
28. Yang Y.B. Yang Y.X. Su B. Tang Y.L. Zhu B.Y. Hu Z.W. Li G.Y. Li Y.J. Liao D.F. Probucol mediates vascular remodeling after percutaneous transluminal angioplasty via down-regulation of the ERK1/2 signaling pathway Eur. J. Pharmacol. 570 2007 125 134
29. Yokoo T. Kitamura M. Antioxidant PDTC induces stromelysin expression in mesangial cells via a tyrosine kinase-AP-1 pathway Am. J. Physiol. 270 1996 806 811
30. Yuan Q. Jiang D.J. Chen Q.Q. Wang S. Xin H.Y. Deng H.W. Li Y.J. Role of asymmetric dimethylarginine in homocysteine-induced apoptosis of vascular smooth muscle cells Biochem. Biophys. Res. Commun. 356 2007 880 885